Synopsys stock analysis: wide moat, AI-driven chip complexity growth, and Ansys deal impact. Read more macro analysis here.

Novo Nordisk A/S still looks like a buy: oral Wegovy growth, solid global demand, 13x forward P/E, and buybacks support upside. Click for this NVO stock update.

Germany is already harnessing AI for smarter production— with virtual factories, robot fleets and its newly launched Industrial AI Cloud. Instead, it targets Germany's industrial heavyweights, ...

A company that specializes in comprehensive medical-legal administration, personal injury assessments, and accredited Occupational Health and Safety (OHS) training, is seeking a Business Analyst & ...

A company that specializes in comprehensive medical-legal administration, personal injury assessments, and accredited Occupational Health and Safety (OHS) training, is seeking a Business Analyst & ...